Login to Your Account



Other News To Note


Monday, September 12, 2011
• Valeant Pharmaceuticals International Inc., of Mississauga, Ontario, said it mailed its offer and takeover bid to shareholders of Afexa Life Sciences Inc., of Edmonton, Alberta. Last month, Valeant made the offer to acquire Afexa for C71 cents (US73 cents) per share, or C$76 million, which trumped an earlier bid by Montreal-based Paladin Labs Inc. Valeant's offer expires at 5 p.m. (Edmonton time) Oct. 17, 2011.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription